USE OF SK1 AS BIOMARKER FOR PREDICTING RESPONSE TO IMMUNECHECKPOINT INHIBITORS

Immune checkpoint inhibitors (ICI) have revolutionized therapy for advanced cancer, however many patients still do not respond to treatment. However, the efficacy and effectiveness of these therapies varies greatly across individual patients and among different tumour types. A substantial unmet need...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	SEGUI, Bruno, MEYER, Nicolas, ANDRIEU-ABADIE, Nathalie, LAMANT-ROCHAIX, Laurence, LEVADE, Thierry, IMBERT, Caroline, COLACIOS VIATGÉ, Céline
Format:	Patent
Sprache:	eng
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!